
Firstkind Limited
Firstkind Ltd manufacture medical devices utilising OnPulse™, the company’s proprietary neuromuscular electro-stimulation technology, which is clinically proven to increase blood circulation for a range of medical conditions.
OnPulseâ„¢ Technology is non-invasive and embedded within the battery powered, portable, one-size-fits-all gekoâ„¢ device. Electrical impulses gently stimulate the common peroneal nerve activating the calf and foot muscle pumps to increase venous, arterial and microcirculatory blood flow, emulating the blood flow rate of walking - up to 60%.
NICE guidance (MTG19) supports the use of the gekoâ„¢ device for people who have a high risk of VTE and for whom pharmacological or other mechanical methods of VTE prevention are impractical or contraindicated. CE marked, the gekoâ„¢ device is also indicated for the prevention and treatment of oedema, promoting wound healing, the treatment of venous insufficiency and ischemia and promoting the healing of tendon and ligament injuries.
An all-round British success story, the fireflyâ„¢ device has been developed, manufactured and brought to market by Firstkind Limited, following a three year programme of applied research with St. Bartholomew's Hospital and Queen Mary, University of London and published clinical studies conducted by Loughborough University.
For more information please visit http://www.gekodevices.com